lyf_dtc_icon_wave_large

What if you had the ability to treat sickle cell disease from within, without a donor?

As a one-time treatment, LYFGENIA works by adding functional copies of the beta-globin [[gene]] to your [[blood stem cells]] to help your body make anti-sickling [[hemoglobin]], so that you can potentially decrease or stop experiencing [[vaso-occlusive events (VOEs)]].

What else should I know about LYFGENIA?

lyf_dtc_icon_gene_82x82
No donor needed
lyfdtcicon1282x82
For ages 12 years or older
with a history of vaso-occlusive
events (VOEs)
lyf_dtc_icon_blood-cells_82x82
Designed to allow for the
production of anti-sickling
hemoglobin to potentially
decrease or stop vaso-occlusive
events (VOEs)
lyf_dtc_icon_gene_82x82
No donor needed
lyfdtcicon1282x82
For ages 12 years or older with a history of vaso-occlusive events (VOEs)
lyf_dtc_icon_blood-cells_82x82
Designed to allow for the production of anti-sickling hemoglobin to potentially decrease or stop vaso-occlusive events (VOEs)
lyf_dtc_graphic_patient-brochure

Check out our Consideration Brochure

This brochure can be a great resource for learning about LYFGENIA. Make sure to have it available and ready when talking to your doctor.
More topics to explore More topics to explore
Back to top